Bar Harbor Campus
The Jackson Laboratory's 43-acre campus is nestled between the Gulf of Maine and the mountains of Acadia National Park, one mile from downtown Bar Harbor. With a staff of more than 1,300 in Bar Harbor, the Laboratory is Downeast Maine's largest employer. That headcount includes more than 200 Ph.D.s, physicians and veterinarians who staff and support the research teams that investigate the genetic basis of cancer, diabetes, Alzheimer's and many other human diseases and disorders.
The research models and focus at The Jackson Laboratory in Bar Harbor have been evolving over the years, and continue to evolve, as scientific discoveries are made and new methods of research are developed. This evolution in science creates ongoing demand for renovations of existing space, construction of new facilities and upgrades or replacements of the infrastructure to support the latest models of scientific research as well as improvements with animal housing to support the mice that are critical to our success. To this end JAX has invested over $200,000,000 in capital over the past ten years in new construction, renovations, equipment upgrades and maintenance at this campus.
Individual capital projects at JAX can range from ten thousand to millions of dollars and require a wide range of trades and trade skills.
Ellsworth Campus
In response to the demand for JAX quality research mice increasing each year, we are engaged in a phased development of our site in Ellsworth, Maine to provide a state-of-the-art animal production facility to meet our current and projected demand. The fourth and final phase of this construction was completed in 2024.
Maine Cancer Genomics Initiative – Augusta
The Jackson Laboratory has established the Maine Cancer Genomics Initiative (MCGI) at the Augusta Campus of MaineGeneral Health. JAX has accomplished key milestones toward its mission of partnering with clinical institutions and oncology practices in Maine to help cancer patients across the state. JAX’s MCGI is working with clinicians from every cancer care provider in Maine to enhance oncology providers’ knowledge of cancer genomic technology and provide access to advanced genomic tests and educational programs to the Maine oncology community. These tests identify mutations that can be targeted by precision medicine treatments.